PSYC 390 CH 1 Flashcards
(63 cards)
absorption
Movement of a drug from the site of administration to the circulatory system
acute tolerance
Rapid tolerance formed during a single administration of a drug as is the case with alcohol
additive effects
Drug interactions characterized by the collective sum of the two individual drug effects
affinity
Attraction between a molecule and a receptor
area postrema
Area in the medulla of the brain stem that is not isolated from chemicals in the blood It is responsible for inducing a vomiting response when a toxic substance is present in the blood
astrocytes
Starshaped cells of the nerve tissue that have numerous extensions and that modulate the chemical environment around neurons metabolically assist neurons and provide phagocytosis for cellular debris
behavioral tolerance
The reduced effectiveness of a drug administered chronically that involves learning either instumental or classical conditioning
bioavailability
Concentration of drug present in the blood that is free to bind to specific target sites
biotransformation
Inactivation of a drug through a chemical change usually by metabolic processes in the liver
classical conditioning
Repeated pairing of a neutral stimulus with an unconditioned stimulus Eventually the neutral stimulus becomes a conditioned stimulus and elicits a conditioned response that is similar to the original unconditioned response
competitive antagonist
Drug that binds to a receptor but has little or no efficacy When it competes with an agonist for receptor sites it reduces the effect of the agonist
concentration gradient
Difference in the amount or concentration of a substance on each side of a biological barrier such as the cell membrane
crosstolerance
Tolerance to a specific drug can reduce the effectiveness of a another drug in the same class
depot binding
Type of drug interaction involving binding to an inactive site such as to proteins in the plasma to bone or to fat
dose response curve
Graph used to display the amount of biological change in relation to a given drug dose
downregulation
Decrease in the number of receptors which may be a consequence of chronic agonist treatment
drug action
Molecular changes associated with a drug binding to a particular target site or receptor
drug competition
Interaction between two drugs that share a metabolic system and compete for the same metabolic enzymes Bioavailability of one or both increases
drug depots
Inactive sites where drugs accumulate There is no biological effect from drugs binding at these sites nor can they be metabolized
drug effects
Alterations in physiological or psychological functions associated with a specific drug
efficacy
The extent to which a ligandreceptor binding initiates a biological action eg the ability of an agonist to activate its receptor
enteral
Drug administration by oral or rectal routes
enzyme induction
Increase in liver drugmetabolizing enzymes associated with repeated drug use
enzyme inhibition
Reduction in liver enzyme activity associated with a specific drug